Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

2,845 total articles

Buy the Pause: PSA as a 4–6 Month Income-and-Growth Rebound

Buy the Pause: PSA as a 4–6 Month Income-and-Growth Rebound

Public Storage (PSA) is in a measured slowdown, but strong cash generation, a near-5% yield and a historically resilient business make the current pullback a structured buying opportunity. This trade lays out an entry at $277.45, a stop at $260.00 and a target of $310.00 over a long-term (180 trading days) horizon.

ASE Technology: Positioning for an AI-Driven Packaging Supercycle

ASE Technology: Positioning for an AI-Driven Packaging Supercycle

ASE Technology (ASX) is a market leader in IC packaging and testing positioned to benefit from accelerating AI, HPC, and 5G demand. Technical momentum and improving short interest underpin a tactical long entry at $19.55 with a $24.00 long-term target (180 trading days) and a $17.00 stop. The valuation is premium (PE ~39) but justified if ASE captu…

Meta's 2026 Setup: Buy the Pullback After a Big Re-rate

Meta's 2026 Setup: Buy the Pullback After a Big Re-rate

Meta's stock ripped higher after an earnings beat and bullish guidance. Fundamentals - strong free cash flow, high ROE, low leverage - justify an upgrade. Technicals show momentum but near-term overbought readings argue for a disciplined entry. Trade plan: enter on weakness, stop tight, target a measured breakout above the prior 52-week high.

Platinum Rebound: A Mid-Term Trade Idea on Sibanye-Stillwater (SBSW)

Platinum Rebound: A Mid-Term Trade Idea on Sibanye-Stillwater (SBSW)

Sibanye-Stillwater (SBSW) pulled back intraday to $19.30 but remains technically constructive and sits well-positioned to benefit from a multi-year platinum/rhodium supply deficit. This trade idea outlines an actionable entry at $19.60, a stop at $18.00 and a target of $24.00 over a mid-term window (~45 trading days), balancing upside from metal fu…

Why Travere's Filspari Approval Odds Look Underpriced at $31.59

Why Travere's Filspari Approval Odds Look Underpriced at $31.59

Travere Therapeutics (TVTX) is trading in a tight range around $31.59 with low-to-moderate volume. Market pricing appears to understate the value of a potential Filspari approval for FSGS. This trade targets a material re-rating on positive regulatory news while keeping a disciplined stop to limit downside if the binary outcome goes the other way.

Capcom: Momentum Ahead of Major Catalysts - A Mid‑Term Long Trade

Capcom: Momentum Ahead of Major Catalysts - A Mid‑Term Long Trade

Capcom (CCOEY) is trading above its near-term moving averages with bullish MACD momentum and a pronounced buildup in short interest and short volume. Those market signals, combined with favorable industry growth projections, argue for a mid-term (45 trading days) long trade capturing upside ahead of major product catalysts. Entry at $12.18, target …

Micron’s Momentum: A Tactical Long for Traders Chasing AI-Driven Upside

Micron’s Momentum: A Tactical Long for Traders Chasing AI-Driven Upside

Micron is trading near fresh 52-week highs on strong AI-driven demand for memory and storage. Fundamentals show healthy profitability and cash generation, while technicals signal momentum — but the stock is extended. This trade idea lays out a concrete entry at $430.55, a stop at $395.00, and a target at $520.00 for a mid-term (45 trading days) swi…

AAOI: Momentum Breakout — Position for the Next Leg Higher

AAOI: Momentum Breakout — Position for the Next Leg Higher

Applied Optoelectronics has rallied from pandemic-era lows into a technically clean uptrend driven by accelerating hyperscale/data-center orders and product wins. The chart breakout is supported by improving fundamentals and heavy short interest that can fuel a squeeze. This trade idea outlines an actionable long with entry, stop and target, plus c…

Pfizer at a Crossroads: High-Yield Income Trade with Mid-Term Upside

Pfizer at a Crossroads: High-Yield Income Trade with Mid-Term Upside

Pfizer offers a generous ~6.7% yield, a below-average valuation (PE ~15, EV/EBITDA ~8.8) and free cash flow roughly $10.4B — characteristics attractive for income-seeking investors. The company also has potential upside from early oncology and weight-management launches. This trade idea lays out a mid-term long plan (45 trading days) with entry, st…